Clinical Trial Update: Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating continuous alloreactive T cell depletion and regulatory T cell expansion for steroid-refractory or dependent chronic graft-ver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: daphne brockington | Conditions: Chronic GVHD After HCT for Cancer or Immune Disease | Phase 2 | Status: UNKNOWN